Tobam Catalent, Inc. Transaction History

Tobam

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$32.18 - $46.57 $277,327 - $401,340	8,618 Added 2.61%	338,255 $15.2 Million
Q3 2023 Oct 31, 2023	BUY	$44.2 - $50.2 $517,316 - $587,540	11,704 Added 3.68%	329,637 $15 Million
Q2 2023 Jul 31, 2023	BUY	$31.86 - $67.26 $10.1 Million - $21.4 Million	317,933 New	317,933 $13.8 Million
Q4 2022 Feb 02, 2023	BUY	$41.39 - $81.0 $79,468 - $155,520	1,920 Added 238.51%	2,725 $123,000
Q1 2022 Apr 25, 2022	BUY	$94.19 - $124.49 $75,822 - $100,214	805 New	805 $89,000
Q4 2020 Feb 03, 2021	SELL	$85.88 - $105.36 $47,491 - $58,264	-553 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $40,225 - $51,152	553 New	553 $47,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.